VRCA: Verrica Pharmaceuticals Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 282.09
Enterprise Value ($M) 255.42
Book Value ($M) 19.76
Book Value / Share 0.47
Price / Book 14.27
NCAV ($M) 15.70
NCAV / Share 0.37
Price / NCAV 17.97

Profitability (mra)
Return on Invested Capital (ROIC) -1.03
Return on Assets (ROA) -0.98
Return on Equity (ROE) -1.03

Liquidity (mrq)
Quick Ratio 4.49
Current Ratio 4.55

Balance Sheet (mrq) ($M)
Current Assets 77.53
Assets 81.60
Liabilities 61.83
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 5.12
Operating Income -63.22
Net Income -67.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -38.58
Cash from Investing -0.36
Cash from Financing 74.21

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G Avoro Capital Advisors LLC 9.99
02-14 13G/A Perceptive Advisors Llc 16.90 40.89

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-29 10-K 35 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 15,287 53,141 28.77
2024-04-25 160,173 57,886 276.70
2024-04-24 8,238 38,499 21.40
2024-04-23 8,621 51,149 16.85
2024-04-22 41,603 105,626 39.39

(click for more detail)

Similar Companies
VCEL – Vericel Corporation VERA – Vera Therapeutics, Inc.
VNDA – Vanda Pharmaceuticals Inc. WVE – Wave Life Sciences Ltd.
XENE – Xenon Pharmaceuticals Inc.


Financial data and stock pages provided by
Fintel.io